Form 4 Filing for John H. Weiland at Solventum Corp

This filing details transactions by John H. Weiland, a director at Solventum Corp (SOLV), on April 30, 2026. Weiland acquired 3,403 shares of Common Stock through the settlement of Restricted Stock Units (RSUs). The RSUs were fully vested and each represented a contingent right to one share of Common Stock. Following this transaction, Weiland holds 8,947 shares of Common Stock directly. The reported value of the transaction was $0, indicating it was part of a compensation or equity award. The filing was signed on May 1, 2026, by Megan Bombick as attorney-in-fact for John H. Weiland.